Mitrionics creates scientific advisory board
Mitrionics has appointed Dietrich Stephan as its first scientific advisory board member, assisting the company's HPC acceleration porfolio of products and its use in genomics and bioinformatics.
Within the genomics and bioinformatics markets, Mitrionics' products dramatically accelerate the most complex bioinformatics codes including sequence search and detection, sequence comparison, mapping and alignment. Its bio IT processing systems exploit the parallel, reconfigurable architecture of field-programmable gate arrays (FPGAs), with 10x to 100x speed increases and as much as 90 per cent less power consumption vs non-accelerated systems. Mitrionics products enable applications engineers and non-expert VHDL programmers to code applications with the free Mitrion C SDK.
'Dr Stephan brings a wealth of experience to our advisory board,' said Magnus Hjern, president and CEO. 'He is an innovator and expert in genetic research applications aimed at determining the root causes of common human diseases and implementing early diagnostics and intervention. He will be a valuable member of the team by helping our products remain on the cutting edge of genome and bioinformatics applications.'
Dr Stephan is the co-founder and chief science officer for Navigenics, a personalised genomics company based in Foster City, California. Navigenics uses DNA analysis to reveal genetic predispositions to important health conditions, and provides additional tools as well as support from board-certified genetic counselors to help individuals understand their results and take action. In his Mitrionics advisory role he will offer expert advice on the present and future demands the genomics industry will place on computational resources.
'With massive data requiring processing to understand connections between disease and the human genome, Mitrionics' software and server solutions provide a great leap forward for genome research and applications,' said Dr Stephan. 'Mitrionics massive processing accelerations are a significant and cost-effective bioinformatics research solution. Working with Mitrionics will create an accelerated computing platform that helps effectively solve the most challenging genetic problems and advance disease treatment and prevention.'